Gallop Oncology
Phase 1/2Harnessing direct tumor cell killing in tandem with potent immune activation. Pioneering a new approach where efficacy, safety and durability live together.
Founded
2020
Focus
AntibodiesBiologics
About
Harnessing direct tumor cell killing in tandem with potent immune activation. Pioneering a new approach where efficacy, safety and durability live together.
Funding History
1Total raised: $4M
Seed$4MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile